BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32006341)

  • 1. Sodium Valproate, a Histone Deacetylase Inhibitor, Provokes Reactive Oxygen Species-Mediated Cytotoxicity in Human Hepatocellular Carcinoma Cells.
    Rithanya P; Ezhilarasan D
    J Gastrointest Cancer; 2021 Mar; 52(1):138-144. PubMed ID: 32006341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive Oxygen Species-Mediated Mitochondrial Dysfunction Triggers Sodium Valproate-Induced Cytotoxicity in Human Colorectal Adenocarcinoma Cells.
    Anirudh BVM; Ezhilarasan D
    J Gastrointest Cancer; 2021 Sep; 52(3):899-906. PubMed ID: 32880040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Effect of the Histone Deacetylase Inhibitor Valproic Acid on Viability and Apoptosis of the PLC/PRF5 Human Hepatocellular Carcinoma Cell Line.
    Sanaei M; Kavoosi F; Roustazadeh A; Shahsavani H
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2507-2510. PubMed ID: 30256044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of DNA Methyltransferase in Comparison to and in Combination with Histone Deacetylase Inhibitors on Hepatocellular Carcinoma HepG2 Cell Line.
    Sanaei M; Kavoosi F
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1119-1125. PubMed ID: 31030484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species generation and mitochondrial dysfunction for the initiation of apoptotic cell death in human hepatocellular carcinoma HepG2 cells by a cyclic dipeptide Cyclo(-Pro-Tyr).
    Karanam G; Arumugam MK
    Mol Biol Rep; 2020 May; 47(5):3347-3359. PubMed ID: 32248385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB.
    Ahmadian E; Eftekhari A; Babaei H; Nayebi AM; Eghbal MA
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1570-1577. PubMed ID: 28356024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.
    Li X; Zhu Y; He H; Lou L; Ye W; Chen Y; Wang J
    Biochem Biophys Res Commun; 2013 Jun; 436(2):259-64. PubMed ID: 23726914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
    Wang Y; Dong L; Li J; Luo M; Shang B
    Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. III-10, a newly synthesized flavonoid, induces cell apoptosis with the involvement of reactive oxygen species-mitochondria pathway in human hepatocellular carcinoma cells.
    Dai Q; Yin Q; Zhao Y; Guo R; Li Z; Ma S; Lu N
    Eur J Pharmacol; 2015 Oct; 764():353-362. PubMed ID: 26164795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringic acid triggers reactive oxygen species-mediated cytotoxicity in HepG2 cells.
    Gheena S; Ezhilarasan D
    Hum Exp Toxicol; 2019 Jun; 38(6):694-702. PubMed ID: 30924378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sodium valproate enhances doxorubicin cytotoxicity in breast cancer cells in vitro].
    Tong XH; Zheng C; Jiang GJ; Dong SY
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):62-5. PubMed ID: 25613611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells.
    Cheng SB; Wu LC; Hsieh YC; Wu CH; Chan YJ; Chang LH; Chang CM; Hsu SL; Teng CL; Wu CC
    J Agric Food Chem; 2012 Sep; 60(38):9620-30. PubMed ID: 22946656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
    Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
    Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro cytotoxicity and induction of apoptosis by silica nanoparticles in human HepG2 hepatoma cells.
    Lu X; Qian J; Zhou H; Gan Q; Tang W; Lu J; Yuan Y; Liu C
    Int J Nanomedicine; 2011; 6():1889-901. PubMed ID: 21931484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triterpenoid pristimerin induced HepG2 cells apoptosis through ROS-mediated mitochondrial dysfunction.
    Guo Y; Zhang W; Yan YY; Ma CG; Wang X; Wang C; Zhao JL
    J BUON; 2013; 18(2):477-85. PubMed ID: 23818365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells.
    Yan F; Wang M; Li J; Cheng H; Su J; Wang X; Wu H; Xia L; Li X; Chang HC; Li Q
    Environ Toxicol Pharmacol; 2012 Mar; 33(2):181-90. PubMed ID: 22222560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine, a Histone Deacetylase Inhibitor Induces Apoptosis in Human Colon Adenocarcinoma Cell Line HT-29.
    Sohaib M ; Ezhilarasan D
    J Gastrointest Cancer; 2020 Jun; 51(2):564-570. PubMed ID: 31407251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid inhibits human hepatocellular cancer cells growth in vitro and in vivo.
    Machado MC; Bellodi-Privato M; Kubrusly MS; Molan NA; Tharcisio T; de Oliveira ER; D'Albuquerque LA
    J Exp Ther Oncol; 2011; 9(2):85-92. PubMed ID: 21699015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
    Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL
    Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors.
    Goehringer N; Biersack B; Peng Y; Schobert R; Herling M; Ma A; Nitzsche B; Höpfner M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.